SAN FRANCISCO - A short-lived drizzle early Tuesday morning failed to dissuade attendees at the 28th annual J.P. Morgan Healthcare conference from turning out to hear biotech behemoths like Genzyme Corp. and Amgen Inc. preview year-end earnings and outline plans for addressing the challenges that have plagued them of late. (BioWorld Today) Read More
